DOJ Guardant Health Reaches False Claims Act Settlement Over Hiring Physician’s… Thomas Sullivan Sep 13, 2024 0 Guardant Health, Inc., a precision oncology company in California, reached a settlement with the United States Department of…
False Claims Act DaVita Reaches $34 Million False Claims Act Settlement Thomas Sullivan Sep 12, 2024 0 DaVita has agreed to pay more than $34 million to resolve allegations that it violated the False Claims Act by paying kickbacks to…
Congress Congress Sends Letter to FDA Regarding Clinical Trials in China Thomas Sullivan Sep 11, 2024 0 A bipartisan group of Representatives in the United States House of Representatives sent a letter to Robert Califf, MD,…
CMS HHS OIG Issues Report on Two Midnight Rule in Medicare Thomas Sullivan Sep 10, 2024 0 CMS estimates that between 2017 and 2021, Medicare Part A improperly paid $23.9 billion for inpatient hospital stays, with $7.8…
CMS CMS Issues 2025 OPPS and ASC Proposed Rule Thomas Sullivan Sep 9, 2024 0 The United States Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) recently…
CME Upcoming MEDX Primary Care Regional Conference Set to Transform Primary… Thomas Sullivan Sep 7, 2024 0 Clinical Education Alliance (Clinical Care Options (CCO) and Practicing Clinicians Exchange (PCE) in collaboration with The…
Uncategorized The Power of PBMs in Oncology: Unveiling the Middlemen: Oncology Update… Thomas Sullivan Sep 6, 2024 0 In the ever-evolving world of oncology, access to effective treatments and their affordability is a constant concern. In Episode 5…
DOJ DOJ Announces Wide-Ranging Health Care Fraud Scheme Charges Thomas Sullivan Sep 5, 2024 0 The Department of Justice recently announced a range of charges against almost 200 individuals accused of participating in health…
CMS AmeriLife Sues HHS Over Broker Compensation Cap Thomas Sullivan Sep 4, 2024 0 AmeriLife Holdings, LLC, Network Insurance Senior Health Division ALG, LLC, and AmeriLife Marketing Group, LLC (“AmeriLife”)…
FDA FDA Releases Draft Guidance on Diversity in Clinical Trials Thomas Sullivan Sep 3, 2024 0 The United States Food and Drug Administration (FDA) released a draft guidance that recommended more diverse patient cohorts in…